Stevens Kris N J, Crespo-Biel Olga, van den Bosch Edith E M, Dias Aylvin A, Knetsch Menno L W, Aldenhoff Yvette B J, van der Veen Frederik H, Maessen Jos G, Stobberingh Ellen E, Koole Leo H
Department of Cardiothoracic Surgery, Maastricht University Medical Centre, P. Debyelaan 25, Maastricht 6229 HX, The Netherlands.
Biomaterials. 2009 Aug;30(22):3682-90. doi: 10.1016/j.biomaterials.2009.03.054. Epub 2009 Apr 26.
It is well known that surface coatings for medical devices can be made antimicrobial through introduction of silver nanoparticles. By virtue of their extremely large surface-to-volume ratio, the silver particles serve as a depot for sustained release of silver ions, despite the fact that silver is not readily oxidized. Antimicrobial coatings are especially important in connection with indwelling catheters with a high risk of bacterial line infections, such as central venous catheters (CVCs). This study specifically addressed the question what the impact of silver nanoparticles (exposed at the coating's surface) and/or the release of silver ions would be on coagulation of contacting blood. Studies, performed in vitro with fresh platelet-rich blood plasma (PRP) from 5 different healthy volunteer donors, clearly pointed out that: (i) the presence of silver nanoparticles correlates with accelerated thrombin formation upon contact of the coating with PRP; (ii) platelet activation is stronger as a result from the contact with silver nanoparticle-containing coatings as compared to other coatings which are devoid of silver. A series of titration experiments, in which the potential effect of silver ions is mimicked, revealed that the observed activation of blood platelets can be best explained through a collision mechanism. The results suggest that platelets that collide with silver, exposed at the surface, become activated without adhering to the surface. These new results point, rather unexpectedly, at a double effect of the silver nanoparticles in the coating: a strong antimicrobial effect occurs simultaneously with acceleration of the coagulation of contacting blood. This new information is, evidently, most relevant for the development of improved surface coatings for indwelling catheters (such as CVCs) which should combine antimicrobial features and close-to-zero thrombogenicity.
众所周知,通过引入银纳米颗粒可以使医疗器械的表面涂层具有抗菌性能。尽管银不易被氧化,但由于银颗粒具有极大的表面积与体积比,它们可作为银离子持续释放的储存库。抗菌涂层对于存在细菌感染高风险的留置导管,如中心静脉导管(CVC),尤为重要。本研究特别探讨了银纳米颗粒(暴露于涂层表面)和/或银离子释放对接触血液凝固的影响。对来自5名不同健康志愿者捐献者的新鲜富血小板血浆(PRP)进行的体外研究清楚地表明:(i)银纳米颗粒的存在与涂层与PRP接触时凝血酶形成加速相关;(ii)与不含银的其他涂层相比,与含银纳米颗粒的涂层接触导致的血小板活化更强。一系列模拟银离子潜在作用的滴定实验表明,观察到的血小板活化最好通过碰撞机制来解释。结果表明,与暴露在表面的银碰撞的血小板会被激活而不粘附于表面。这些新结果相当出乎意料地指出了涂层中银纳米颗粒的双重作用:在产生强大抗菌作用的同时,加速接触血液的凝固。显然,这一新信息对于开发改进的留置导管(如CVC)表面涂层最为相关,这种涂层应兼具抗菌特性和接近零的血栓形成性。